PAGP

Plains GP Holdings LP

Add to Watchlist

Advanced Chart

19.230

-0.01(-0.052%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

19.385

Open

19.300

VWAP

19.27

Vol

191.37K

Mkt Cap

3.80B

Low

19.180

Amount

3.69M

EV/EBITDA(TTM)

12.23

Total Shares

197.25M

24.79B

EV/OCF(TTM)

10.15

P/S(TTM)

Plains GP Holdings, L.P. through Plains All American Pipeline, L.P. (PAA), owns and operates midstream energy infrastructure and provides logistics services for crude oil and natural gas liquids (NGL). The Company operates through two segments: Crude Oil and NGL. The Crude Oil segment operations generally consist of gathering and transporting crude oil using pipelines (including gathering systems), trucks, and at times on barges or railcars, in addition to providing terminalling, storage and other related services utilizing its integrated assets across the United States and Canada. The NGL segment operations involve natural gas processing and NGL fractionation, storage, transportation and terminalling. The NGL segment is engaged in providing gathering, fractionation, storage, and/or terminalling services to third-party customers, extracting NGL mix from the gas stream processed at its Empress straddle plant facility as well as acquiring NGL mix.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

13.41B

+11.61%

14.84B

+19.64%

13.48B

+5.82%

Estimates Revision

The market is revising Downward the revenue expectations for Plains GP Holdings, L.P. (PAGP) for FY2025, with the revenue forecasts being adjusted by -7.24% over the past three months. During the same period, the stock price has changed by 4.40%.

Revenue Estimates for FY2025

Revise Downward

-7.24%

In Past 3 Month

Stock Price

Go Up

+4.40%

In Past 3 Month

8 Analyst Rating

7.70% Upside

Wall Street analysts forecast PAGP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PAGP is 20.71 USD with a low forecast of 18.00 USD and a high forecast of 23.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

5 Hold

1 Sell

Hold

7.70% Upside

Current: 19.230

Low

18.00

Averages

20.71

High

23.00

7.70% Upside

Current: 19.230

Low

18.00

Averages

20.71

High

23.00

Wolfe Research

Outperform -> Peer Perform

downgrade

2025-07-25

Reason

Wolfe Research

Price Target

2025-07-25

downgrade

Outperform -> Peer Perform

Reason

Wolfe Research downgraded Plains GP Holdings to Peer Perform from Outperform without a price target. The firm cites valuation for the downgrade following the recent rally.

Mizuho

Outperform

maintain

$20 -> $22

2025-06-19

Reason

Mizuho

Price Target

$20 -> $22

2025-06-19

maintain

Outperform

Reason

Mizuho raised the firm's price target on Plains GP Holdings to $22 from $20 and keeps an Outperform rating on the shares. The firm expects a positive market reaction to Plains' sale of its Canadian natural gas liquids business to Keyera. The deal lends credence to the view Plains could use proceeds to buy in the Plains-Oryx Permian joint venture, and/or position itself as a cleaner pure-play crude story that is better positioned to participate in potential industry consolidation, the analyst tells investors in a research note.

JPMorgan

Jeremy Tonet

Neutral

maintain

$19 -> $20

2025-06-19

Reason

JPMorgan

Jeremy Tonet

Price Target

$19 -> $20

2025-06-19

maintain

Neutral

Reason

JPMorgan analyst Jeremy Tonet raised the firm's price target on Plains GP Holdings to $20 from $19 and keeps a Neutral rating on the shares. The Canadian natural gas liquids divestiture "creates meaningful capital allocation optionality" for Plains, the analyst tells investors in a research note.

Mizuho

Outperform

downgrade

$21 -> $20

2025-05-20

Reason

Mizuho

Price Target

$21 -> $20

2025-05-20

downgrade

Outperform

Reason

Mizuho lowered the firm's price target on Plains GP Holdings to $20 from $21 and keeps an Outperform rating on the shares. The firm updated midstream estimates post the Q1 reports. Midstream's Q1 reporting cycle seemed to confirm that the near-term outlook across the group is mostly unchanged, but investors will focus on posturing around growth in fiscal 2026 and beyond, the analyst tells investors in a research note.

Citi

Neutral

downgrade

$21 -> $18

2025-05-13

Reason

Citi

Price Target

$21 -> $18

2025-05-13

downgrade

Neutral

Reason

Citi lowered the firm's price target on Plains GP Holdings to $18 from $21 and keeps a Neutral rating on the shares. The firm reduced estimates to reflect lower cash flow expectations driven by a moderated Permian growth outlook over the near-term.

Barclays

Theresa Chen

Sell

Maintains

$19 → $18

2025-04-10

Reason

Barclays

Theresa Chen

Price Target

$19 → $18

2025-04-10

Maintains

Sell

Reason

Barclays analyst Theresa Chen lowered the firm's price target on Plains GP Holdings to $18 from $19 and keeps an Underweight rating on the shares. Following Plains All American's recent bolt-on acquisitions, the firm looks for volumetric growth across the partnership's crude segment as well as steady base business performance through the remainder of 2025.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Plains GP Holdings LP (PAGP.O) is 15.72, compared to its 5-year average forward P/E of 16.57. For a more detailed relative valuation and DCF analysis to assess Plains GP Holdings LP 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

16.57

Current PE

15.72

Overvalued PE

35.18

Undervalued PE

-2.05

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

9.41

Current EV/EBITDA

9.02

Overvalued EV/EBITDA

10.44

Undervalued EV/EBITDA

8.38

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Overvalued

5Y Average PS

0.06

Current PS

0.07

Overvalued PS

0.07

Undervalued PS

0.04